Built to Protect Your License, Your Clinic, and Your Patients.
At Synergy, we don’t just teach stem cell procedures. We train physicians to operate by the book. Our compliance and FDA-alignment framework is designed to help clinics confidently offer regenerative therapies while minimizing regulatory risk and maintaining professional credibility.
FDA & FCC Guideline EducationWe do not promise shortcuts, loopholes, or gray-area medicine.
We focus on education, structure, and operational discipline, so you can practice with confidence and sleep at night knowing your clinic is positioned correctly. Instead, we train clinics to align their operations, documentation, marketing, and patient communication with current FDA expectations and industry best practices under:
- 21 CFR Part 1271 (HCT/P framework)
- Minimal manipulation and homologous use principles
- Ethical patient consent and disclosure standards
- Conservative, defensible clinical positioning
Our goal is simple: reduce exposure, reduce confusion, and increase long-term sustainability.
Multidisciplinary ReviewFour areas we help clinics get right.
We help clinics build defensible operational structures, including intake workflows, procedure documentation, and internal protocols that support compliance. The focus is on disciplined processes that protect the clinic and physician, not excessive bureaucracy.
We train clinics to align marketing, websites, and patient communications with FDA-safe positioning and regulatory expectations. This includes removing risky language, avoiding outcome-based claims, and educating staff on compliant patient conversations.
We guide clinics in using clear, ethical informed-consent practices that set proper expectations and avoid misleading claims. Strong documentation and transparency protect both the physician and the patient while reinforcing professional credibility.
Regenerative medicine regulations continue to evolve, and we provide ongoing guidance to help clinics adapt responsibly. Our updates focus on best practices, enforcement trends, and operational adjustments to support long-term compliance.
“At Synergy we’re very intentional about how patients and the public are educated. We emphasize understanding over promises, research-based positioning, clear limitations, and honest disclosures because trust is built through transparency, not hype.”Perry Myers · Founder, Synergy
Built to Last.
You shouldn’t have to choose between innovation and compliance. We believe the strongest clinics are built on structure, transparency, and disciplined processes, not shortcuts. Long-term success comes from doing things the right way early, so physicians can grow with confidence and credibility.
Good medicine and compliance are not separate, they work together.
Strong clinics are built on clear systems, documentation, and disciplined processes.
Progress in regenerative medicine must be paired with ethical and regulatory awareness.
Clinics that establish compliance and structure early avoid costly corrections later.
For Clinics That Value Compliance and Credibility.
This program is designed for physicians who intend to practice regenerative medicine responsibly and sustainably for the long term. It is ideal for clinics that prioritize professional reputation, license protection, and ethical patient care over short-term gains.
Synergy is a strong fit for doctors who prefer conservative, defensible clinical approaches and want clear guidance on regulatory expectations. It also serves practices seeking steady growth without the constant stress of regulatory uncertainty, marketing risk, or compliance-related distractions.
Real cases. Real consequences.
3 charged with performing unlicensed stem cell operations in Draper
DRAPER — Three people, including a licensed orthopedic surgeon and another man whose license was revoked years ago, are accused of performing unlicensed stem cell operations in Draper.
Read the article →
AG Ferguson files lawsuit against US Stemology for peddling unproven, untested stem cell treatments
OLYMPIA — Attorney General Bob Ferguson filed a lawsuit against Seattle-based US Stemology and its owner, Dr. Tami Meraglia, for deceptively marketing stem cell treatments for COVID-19.
Read the article →
Stem Cell Institute Co-Founders and Companies Banned from Marketing Stem Cell Treatments and Ordered to Pay More Than $5.1 Million
Under federal district court orders announced today, the co-founders of the Stem Cell Institute of America and several related companies are banned from marketing stem cell therapy in the future.
Read the article →Want a Zoom Call With Our Team?
Curious about stem cells? Let’s chat! We’ll talk about what utilizing stem cells might look like for you and your practice. No pressure, no obligation.
Contact Us To Learn More.
Built by doctors, for doctors. You retain full clinical control, medical decision-making, and patient ownership. No corporate pressure, no treatment quotas.
Designed to help you operate by the book with FDA-aware protocols, documentation guidance, and risk-reduction frameworks that protect your license and your practice.
We handle the systems, education, and infrastructure so you can expand regenerative services confidently, without reinventing workflows or overloading your staff.